312 related articles for article (PubMed ID: 21800959)
1. The molecular biology and novel treatments of vestibular schwannomas.
Fong B; Barkhoudarian G; Pezeshkian P; Parsa AT; Gopen Q; Yang I
J Neurosurg; 2011 Nov; 115(5):906-14. PubMed ID: 21800959
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis and molecular pathology of vestibular schwannoma].
Brodhun M; Stahn V; Harder A
HNO; 2017 May; 65(5):362-372. PubMed ID: 27421984
[TBL] [Abstract][Full Text] [Related]
3. Molecular biology of vestibular schwannomas.
Chang LS; Welling DB
Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
[TBL] [Abstract][Full Text] [Related]
4. The molecular biology of vestibular schwannomas: dissecting the pathogenic process at the molecular level.
Neff BA; Welling DB; Akhmametyeva E; Chang LS
Otol Neurotol; 2006 Feb; 27(2):197-208. PubMed ID: 16436990
[TBL] [Abstract][Full Text] [Related]
5. Molecular studies of vestibular schwannomas: a review.
Welling DB; Packer MD; Chang LS
Curr Opin Otolaryngol Head Neck Surg; 2007 Oct; 15(5):341-6. PubMed ID: 17823551
[TBL] [Abstract][Full Text] [Related]
6. [Neurotrophic factor expression in vestibular schwannoma. An overview].
Diensthuber M; Lenarz T; Stöver T
Laryngorhinootologie; 2006 Oct; 85(10):731-7. PubMed ID: 16612755
[TBL] [Abstract][Full Text] [Related]
7. Tumor Biology of Vestibular Schwannoma: A Review of Experimental Data on the Determinants of Tumor Genesis and Growth Characteristics.
de Vries M; van der Mey AG; Hogendoorn PC
Otol Neurotol; 2015 Aug; 36(7):1128-36. PubMed ID: 26049313
[TBL] [Abstract][Full Text] [Related]
8. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma.
Agnihotri S; Gugel I; Remke M; Bornemann A; Pantazis G; Mack SC; Shih D; Singh SK; Sabha N; Taylor MD; Tatagiba M; Zadeh G; Krischek B
J Neurosurg; 2014 Dec; 121(6):1434-45. PubMed ID: 25245477
[TBL] [Abstract][Full Text] [Related]
9. Gene discovery using a human vestibular schwannoma cDNA library constructed from a patient with neurofibromatosis type 2 (NF2).
Halum SL; Erbe CB; Friedland DR; Wackym PA
Otolaryngol Head Neck Surg; 2003 Mar; 128(3):364-71. PubMed ID: 12646839
[TBL] [Abstract][Full Text] [Related]
10. Retinoblastoma-cyclin-dependent kinase pathway deregulation in vestibular schwannomas.
Lasak JM; Welling DB; Akhmametyeva EM; Salloum M; Chang LS
Laryngoscope; 2002 Sep; 112(9):1555-61. PubMed ID: 12352662
[TBL] [Abstract][Full Text] [Related]
11. Updates on Tumor Biology in Vestibular Schwannoma.
Nourbakhsh A; Dinh CT
Otolaryngol Clin North Am; 2023 Jun; 56(3):421-434. PubMed ID: 37121611
[TBL] [Abstract][Full Text] [Related]
12. Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas.
Cumpston EC; Rhodes SD; Yates CW
Curr Oncol Rep; 2023 May; 25(5):531-537. PubMed ID: 36933171
[TBL] [Abstract][Full Text] [Related]
13. A non-NF2 case of schwannomas of vestibular and trigeminal nerves with different genetic alterations of NF2 gene: case report.
Kambe A; Kamitani H; Watanabe T; Oka A; Inagaki H; Ishii T; Ueki K
Surg Neurol; 2005 Jan; 63(1):62-4; discussion 64-5. PubMed ID: 15639530
[TBL] [Abstract][Full Text] [Related]
14. cDNA microarray analysis of vestibular schwannomas.
Welling DB; Lasak JM; Akhmametyeva E; Ghaheri B; Chang LS
Otol Neurotol; 2002 Sep; 23(5):736-48. PubMed ID: 12218628
[TBL] [Abstract][Full Text] [Related]
15. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells.
Bian LG; Sun QF; Tirakotai W; Zhao WG; Shen JK; Luo QZ; Bertalanffy H
Chin Med J (Engl); 2005 Sep; 118(18):1517-24. PubMed ID: 16232328
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics.
Sughrue ME; Yeung AH; Rutkowski MJ; Cheung SW; Parsa AT
J Neurosurg; 2011 Feb; 114(2):359-66. PubMed ID: 19943731
[TBL] [Abstract][Full Text] [Related]
18. Schwannomas exhibit distinct size-dependent gene-expression patterns.
Mehrian-Shai R; Freedman S; Shams S; Doherty J; Slattery W; Hsu NY; Reichardt JK; Andalibi A; Toren A
Future Oncol; 2015; 11(12):1751-8. PubMed ID: 26075443
[TBL] [Abstract][Full Text] [Related]
19. Development of drug treatments for neurofibromatosis type 2-associated vestibular schwannoma.
Blakeley J
Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):372-9. PubMed ID: 22931905
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
Bachir S; Shah S; Shapiro S; Koehler A; Mahammedi A; Samy RN; Zuccarello M; Schorry E; Sengupta S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
